New imaging agent could sharpen disease detection in PET scans
NCT ID NCT07253753
First seen Jan 05, 2026 · Last updated May 29, 2026 · Updated 18 times
Summary
This early-stage study tests a new imaging agent called NeuCaVis in 12 healthy volunteers. NeuCaVis is designed to make PET scans clearer by highlighting areas of inflammation, which could help doctors spot diseases more easily in organs like the brain and heart. Participants will receive the agent and undergo several scans to check its safety and how it spreads in the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Ottawa Heart Institute
RECRUITINGOttawa, Ontario, Canada
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.